Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux[S]

Studies in lipoprotein kinetics almost exclusively rely on steady-state approaches to modeling. Herein, we have used a non-steady-state experimental design to examine the role of cholesteryl ester transfer protein (CETP) in mediating HDL-TG flux in vivo in rhesus macaques, and therefore, we develope...

Full description

Saved in:
Bibliographic Details
Published inJournal of lipid research Vol. 57; no. 3; pp. 398 - 409
Main Authors McLaren, David G., Previs, Stephen F., Phair, Robert D., Stout, Steven J., Xie, Dan, Chen, Ying, Salituro, Gino M., Xu, Suoyu S., Castro-Perez, Jose M., Opiteck, Gregory J., Akinsanya, Karen O., Cleary, Michele A., Dansky, Hayes M., Johns, Douglas G., Roddy, Thomas P.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2016
The American Society for Biochemistry and Molecular Biology
Elsevier
Subjects
Online AccessGet full text
ISSN0022-2275
1539-7262
1539-7262
DOI10.1194/jlr.M063842

Cover

More Information
Summary:Studies in lipoprotein kinetics almost exclusively rely on steady-state approaches to modeling. Herein, we have used a non-steady-state experimental design to examine the role of cholesteryl ester transfer protein (CETP) in mediating HDL-TG flux in vivo in rhesus macaques, and therefore, we developed an alternative strategy to model the data. Two isotopomers ([2H11] and [13C18]) of oleic acid were administered (orally and intravenously, respectively) to serve as precursors for labeling TGs in apoB-containing lipoproteins. The flux of a specific TG (52:2) from these donor lipoproteins to HDL was used as the measure of CETP activity; calculations are also presented to estimate total HDL-TG flux. Based on our data, we estimate that the peak total postprandial TG flux to HDL via CETP is ∼13 mg·h−1·kg−1 and show that this transfer was inhibited by 97% following anacetrapib treatment. Collectively, these data demonstrate that HDL TG flux can be used as a measure of CETP activity in vivo. The fact that the donor lipoproteins can be labeled in situ using well-established stable isotope tracer techniques suggests ways to measure this activity for native lipoproteins in free-living subjects under any physiological conditions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2275
1539-7262
1539-7262
DOI:10.1194/jlr.M063842